Posted by sour_grape_so_sour > 2020-08-12 07:38 | Report Abuse

actually ubat also down since last week.....it it the liquidity draining away

Posted by ikenduit > 2020-08-19 10:25 | Report Abuse

when is the awesome QR coming out?

Posted by chwenshiangan > 2020-08-24 15:21 | Report Abuse

any news

Posted by awesomeliddat > 2020-08-24 21:20 | Report Abuse

good fundamental, promising

Posted by LA777 > 2020-08-25 12:05 | Report Abuse

Ahealth go go go!!!

Posted by LA777 > 2020-08-25 12:07 | Report Abuse

Buy to keep, 1st TP 6.

Posted by 1Anchovy > 2020-08-25 12:49 | Report Abuse

Can still buy in at this price?

Posted by LA777 > 2020-08-25 13:13 | Report Abuse

Good fundamental stock, buy now before shooting up soon!!!

Posted by Sinoboy > 2020-08-25 13:46 | Report Abuse

Also goreng counter, from 4.18 to 3.96 in half hour...

Posted by thundery > 2020-08-25 17:13 | Report Abuse

Purely Goreng, stay away

Posted by Coffin Dance > 2020-08-25 17:53 | Report Abuse

Ahealth is a good counter all the while just that the current pricing have element of speculation

Posted by CharKuayTeow > 2020-08-26 08:46 | Report Abuse

i also think this one goreng goreng gila babi

Posted by jowong7 > 2020-08-26 19:05 | Report Abuse

INTERIM FINANCIAL STATEMENTS FOR THE SECOND QUARTER ENDED 30 JUNE 2020

"Expansion of cold chain distribution facilities, essential for vaccine distribution, has been completed in Singapore and will be completed by the fourth quarter in Malaysia."

Posted by jowong7 > 2020-08-26 19:15 | Report Abuse

Capacity Increase for Cold Chain Vaccine Distribution In addition, the Group also reported that expansion of its cold chain distribution facilities, essential for vaccine distribution, has been completed in Singapore and will be completed by the fourth quarter of 2020 in Malaysia.
“For many years now, we have been supplying a wide range of vaccines and biologicals under cold chain distribution specifications directly to many healthcare professionals in Malaysia and Singapore. The planned capacity increase is timely as volume is growing. We will also be ready to play our role in the supply chain when vaccines for COVID-19 become available” added Dr Kee

Posted by khuen > 2020-08-26 22:04 | Report Abuse

Vaccine distribution! Thumbs Up!

Posted by JaBerry > 2020-08-27 09:29 | Report Abuse

Quarter report good. Business growth. Facemask, santinizer, Vit C, Thermometer etc all up.

Posted by newinvestor17 > 2020-08-27 10:13 | Report Abuse

A report published by Sui Li of PBB stated that there were no suprises in this counter ?

Nabeh KNN MCB, this analyst really knows how to value companies ka ? I am suprised that she didnt find any suprises.

This analyst must be one sei so hai who randomly writes reports based on her mood, just look at her Top Glove reports KNN

Her two bosses never checks her report before publishing ka ?

When a counters TP should be increased, they decrease it and when it should be decreased, they increase it

Really no direction punya amoi and research house

Posted by enigmatic [control your emotions, discipline your mind] > 2020-08-27 10:45 | Report Abuse

Then write an analysis report which is better than hers to "teach" her. Empty cans make the most noise.

Posted by chshzhd > 2020-08-28 10:46 | Report Abuse

cheaper than dpharma ..

Posted by chshzhd > 2020-08-28 22:37 | Report Abuse

Just a myth. Contrary to popular belief, pharmaceutical companies like ApexH are also faced with an uncertain outlook for 2H2020 due to disruptions caused by the pandemic. Weaker consumer sentiment and cautious spending has impacted ApexH’s sales, while the deferment elective medical procedures like orthopaedic surgeries has resulted in lower demand for Straits Apex’s orthopaedic devices. However, during this tough time, ApexH has also completed its cold chain distribution expansion in Singapore, while the expansion in Malaysia is expected to complete in 4QFY20. Given that cold chain distribution is vital for the distribution of vaccine, we are positive on this timely expansion as ApexH would be able to expand into vaccine distribution, be it a Covid-19 vaccine or other vaccines available. However, contrary to market’s belief, we are not expecting immediate benefit arising from any potential vaccine distribution by Apex
Source: PublicInvest Research - 27 Aug 2020

Posted by LiimInvest > 2020-08-29 23:06 | Report Abuse

Growing & Fundamental

Posted by mayongzheng > 2020-09-01 20:54 | Report Abuse

https://youtu.be/eIgQAOLapj8

Posted by Wilfred51a > 2020-09-12 20:29 | Report Abuse

https://news.cgtn.com/news/2020-09-11/Hundreds-of-thousands-have-been-given-Chinese-COVID-19-vaccines-THnoo6BcFG/index.html

Posted by Benlee88888 > 2020-09-15 21:33 | Report Abuse

https://www.klsescreener.com/v2/news/view/728195

Posted by Benlee88888 > 2020-09-15 21:33 | Report Abuse

Ini kali lah

Posted by LiimInvest > 2020-09-15 22:41 | Report Abuse

Next TP over 5.00

Posted by GorengHealthcare > 2020-09-16 22:01 | Report Abuse

joined to goreng

Posted by humongainz > 2020-09-16 22:03 | Report Abuse

brother goreng oil la healthcare how can use for goreng aiyaiyai

Posted by hahasong > 2020-09-17 09:33 | Report Abuse

United States vaccine failed!

The glove unit ESCERAM 0100 is about to fly!

Posted by Wilfred51a > 2020-09-20 19:50 | Report Abuse

https://www.theedgemarkets.com/article/malaysia-join-covax-vaccine-plan

Posted by Alfonso > 2020-09-25 16:29 | Report Abuse

jom nasi goreng to the best of the best

Posted by LiimInvest > 2020-10-01 23:45 | Report Abuse

吉隆坡1日讯）紧随政府的疫苗采购有进展，驱动大马股市的疫苗概念股在10月第一个交易日纷纷上涨。

发马联合药业受激励

受政府委定为疫苗灌封商的发马(PHARMA,7081,主板医疗保健组)受消息激励，闭市涨38仙（8.8%）至4令吉70仙；联合药业(DPHARMA,7148,主板医疗保健组)起32仙（10.1%）至3令吉48仙，双双跻身10大上涨股。

上述两股皆以接近最高与最高收市，发马成交量176万7600股，联合药业1629万6500股成交。

另一医疗保健股艾柏士保健(AHEALTH,7090,主板医疗保健组)涨9仙至3令吉33仙。

他说，政府通过多种管道和层面去洽谈采购疫苗，并希望越快越好。

“一旦获得卫生部旗下的大马药剂监管局（NPRA）批准，我国尽量在最短的时间内取得或购买冠病疫苗。”

Posted by 50Cents > 2020-10-08 01:22 |

Post removed.Why?

Posted by NPRA1985 > 2020-10-25 00:22 | Report Abuse

How are the fundamentals of this stock? Good or bad?

Posted by LiimInvest > 2020-10-28 00:10 | Report Abuse

Very Good fundamental

Posted by NPRA1985 > 2020-11-07 02:31 | Report Abuse

Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December

“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”

https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true

Posted by serendipity89 > 2020-11-10 22:10 | Report Abuse

https://www.malaymail.com/news/malaysia/2020/11/10/buying-covid-19-vaccines-not-so-quick-as-no-infrastructure-yet-dr-noor-hish/1921347

Ahealth management has good business sense. Getting ready cold chain in sg and msia to distribute vaccine.

Posted by NPRA1985 > 2020-11-10 23:54 | Report Abuse

Efficacy of Sinopharm vaccine is higher than Pfizer vaccine. Sinopharm vaccine showed 100% efficacy while Pfizer vaccine only showed 90% efficacy.

-----------

US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while SINOPHARM's inactivated vaccine SHOWED 100 PERCENT efficacy at one case in Mexico, both are promising results and have brought about hope of wider use in the fight against the coronavirus, experts said.

Pfizer's announcement got world's attention and many news outlets reported it with enthusiasm, but Sinopharm's vaccine, which have been used on 56,000 people who have traveled abroad, none of whom became infected, were challenged by many Western media when the data was released.

The different reaction revealed Western media's double standard on vaccines for China and the US, with an aim to politicize the issue, Chinese experts said.

Pfizer's 90 percent was based on phase III clinical trials while Sinopharm's is based on observation after emergency use. Although the former has greater authority academically, the latter is also a control study, Tao further explained, noting that the fact 56,000 people did not get infected could serve as a reference for the vaccine's efficacy.

But a major challenge for mRNA vaccines is the temperature requirement for storage - minus 70C for long-term stability in comparison to 2-8 C for the majority of other types of vaccine, Tao noted, "Storage and transportation will be very expensive."

https://www.globaltimes.cn/content/1206389.shtml

Posted by NPRA1985 > 2020-11-11 00:07 | Report Abuse

Sinovac vaccine is not related to any companies in Malaysia but just wanted to share anyway.

------------
Brazilian politics, US pressure likely behind Chinese vaccine's suspension: experts

The Chinese Foreign Ministry, the Chinese vaccine producer and a Brazilian institute clarified that Brazilian health regulator's decision to halt trials of a Chinese-produced COVID-19 vaccine in Brazil is NOT RELATED TO THE VACCINE ITSELF, after foreign media said the suspension came following a "severe adverse event."

Chinese experts said politicization of vaccine issues by some Brazilian politicians was likely the reason. They said the vaccine trial issue, which is life-saving work amid the COVID-19 pandemic, should not be influenced by Brazilian political disputes or US pressure.

They stressed that the vaccine is essential to fight the virus, but the suspension without a reasonable excuse could slow down the vaccine-development process.

Wang Wenbin, spokesperson of the ministry, said at a press conference on Tuesday we notice that BUTANTAN INSTITUTE, partner of China's Sinovac Biotech in Brazil, has concluded that the reported "adverse event" that caused Brazil's health regulator on Monday to suspend trials of a Chinese-produced vaccine in Brazil was NOT RELATED TO THE VACCINE produced by Sinovac.

https://www.globaltimes.cn/content/1206393.shtml

Posted by serendipity89 > 2020-11-11 08:48 | Report Abuse

https://www.theedgemarkets.com/article/apex-healthcare-ready-play-role-vaccine-distribution

Posted by JaBerry > 2020-11-11 09:52 | Report Abuse

People jump to vaccine company. Do we realise without supply chain and logistics also problem? Apex play important roles and has facilities and temperature control in distributing the vaccine.

Posted by NPRA1985 > 2020-11-13 21:54 | Report Abuse

China National Pharmaceutical Group Corp (SINOPHARM), a Chinese state-owned enterprise, announced on Wednesday that data from late-stage clinical trials for its Covid-19 vaccine are «BETTER THAN EXPECTED», Reuters reported.

In Morocco, Dr. Abdelhakim Yahyane, a member of the National Scientific Advisory Committee on Vaccination, told Yabiladi earier this week that vaccine trials in the country «have REACHED THE FINAL PHASE».

We are impatiently awaiting the end of this process, which could probably happen BY NEXT WEEK

https://en.yabiladi.com/articles/details/101544/conducted-morocco-among-others-sinopharm-s.html

Posted by Sinoboy > 2020-11-16 20:17 | Report Abuse

If moderna vaccine is for real, apex health can play a substantial role. Apparently, moderna's vaccine requires storage of only -20C. This is exactly what apex health has, storage facilities that meet this requirement.
Hopefully, such important information is not lost on the public. This counter has great potential

Posted by Russell > 2020-11-16 21:13 | Report Abuse

Eventually vaccine makers will need to come to Apex Healthcare for its cold chain facility which will be completed in Q4. It just completed it’s cold chain in Singapore. Perfect stock for the recovery trend

Posted by Sinoboy > 2020-11-19 18:13 | Report Abuse

Hopefully today's uptrend can be maintained...

Posted by serendipity89 > 2020-11-19 19:46 | Report Abuse

profit seems to have recovered back to pre covid level. next to see is after they completed their cold chain network, whehter they are able to secure distribution contract for the vaccine.

Posted by LiimInvest > 2020-11-20 00:05 | Report Abuse

Apex Pharma

On 14th September, the Group’s wholly owned manufacturing subsidiary Xepa-Soul Pattinson (M) Sdn Bhd secured renewal of its GMP status with the National Pharmaceutical Regulatory Authority (‘NPRA’) through a scheduled desktop audit. In the quarter, Apex Pharma Marketing Pte Ltd in Singapore increased its cold chain distribution capabilities with the expansion of its current 2-8 degrees C cold room and the acquisition of a -20 degrees C freezer room for pharmaceuticals, vaccines and biologics. Expansion of cold chain distribution capacity in Malaysia is scheduled for completion before the end of the current financial year.
Review of Year To Date Performance versus Corresponding Period Last Year

Posted by DreamGuardian > 2020-11-20 00:06 | Report Abuse

Waah

Posted by DreamGuardian > 2020-11-20 00:06 | Report Abuse

Up 8 sen

Posted by DreamGuardian > 2020-11-20 00:06 | Report Abuse

Up 2.27%